Inactive Instrument

Meda AB Share Price

Stocks

End-of-day quote Nasdaq Stockholm
- ^SEK	-

20/07/16	Meda : Mylan gets EU approval for Meda purchase, subject to conditions	RE
15/07/16	Exclusive - Mylan to get EU green light for Swedish drugmaker deal: sources	RE

20/07/16	Meda : Mylan gets EU approval for Meda purchase, subject to conditions	RE
15/07/16	Exclusive - Mylan to get EU green light for Swedish drugmaker deal: sources	RE
02/06/16	Meda : EU regulators to rule on Mylan's $7.2 billion Meda bid by July 6	RE
09/03/16	Valeant Pharmaceuticals Intl : gives Pershing Square one board seat, adds two other directors	RE
11/02/16	Abbott Laboratories : Mylan to buy Swedish drugmaker Meda in $7.2 billion deal	RE
15/01/16	Meda : Swedish drug firm Meda nears deal to sell U.S. business - sources	RE
14/07/14	AbbVie : Shire ready to bow to AbbVie's increased $53 billion offer	RE
12/07/14	Abbott Laboratories : Mylan near multibillion-dollar deal for Abbott drug assets - sources	RE
12/07/14	Abbott Laboratories : Exclusive: Mylan near multibillion-dollar deal for Abbott drug assets - sources	RE
15/05/14	Banks vie for fees as Nordic deal scene ignites	RE
06/05/14	Actavis : Factbox - M&A frenzy transforming global pharma	RE
06/05/14	Actavis : M&A frenzy in healthcare sector	RE
01/05/14	Actavis : Pfizer's designs on AstraZeneca stir tax envy among rivals	RE

25/08/16	Meda : Bulletin from the Extraordinary General Meeting in Meda AB (publ)	BU
08/08/16	Meda : Delisting of Meda Aktiebolag (publ)	BU
05/08/16	MEDA: Notice to noteholders regarding change of control	BU
02/08/16	Meda : Aktiebolag (publ) applies for delisting and convenes an extraordinary general meeting	BU
02/08/16	Meda : Extraordinary General Meeting of Meda Aktiebolag (publ)	BU

20/07/16	Mylan NV : La CE autorise Mylan à racheter Meda sous conditions
15/07/16	Meda : L'UE devrait accepter le rachat de Meda par Mylan-sources
11/02/16	Cisco Systems : Wall Street ouvre en net recul
11/02/16	Wall Street ouvre en baisse, craintes sur la croissance mondiale
11/02/16	Meda : BOURSE-Meda s'envole de plus de 70% après son rachat par Mylan

Manager	Title	Age	Since
Lars Henrik Andreas Rejnus CEO	Chief Executive Officer	52	-
Mårten Österlund LAW	General Counsel	69	08/12/2014
Rainer Weiss CTO	Chief Tech/Sci/R&D Officer	64	31/12/2004

Director	Title	Age	Since
Colleen Ostrowski BRD	Director/Board Member	53	24/08/2016
Caroline Rebecca Louise Dixon BRD	Director/Board Member	58	24/08/2016
Lars Henrik Andreas Rejnus CHM	Chairman	52	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ELI LILLY AND COMPANY	+0.50%	+2.20%	+63.86%	+118.65%	1,055B
JOHNSON & JOHNSON	+0.55%	+1.43%	+50.49%	+74.22%	654B
ABBVIE INC.	+0.99%	+1.09%	+19.81%	+75.61%	467B
ROCHE HOLDING AG	-1.36%	-2.58%	+38.77%	+42.33%	348B
NOVARTIS AG	+1.34%	+4.53%	+22.56%	+29.55%	275B
ASTRAZENECA PLC	-0.48%	-0.54%	+12.66%	+13.50%	258B
AMGEN INC.	+0.73%	+6.32%	+52.57%	+54.35%	224B
GILEAD SCIENCES, INC.	+0.40%	+0.84%	+34.81%	+101.30%	187B
NOVO NORDISK A/S	-0.30%	-2.98%	-28.24%	-61.28%	171B
Average	+0.28%	+0.74%	+29.70%	+49.80%	404.26B
Weighted average by Cap.	+0.37%	+1.32%	+40.15%	+70.37%